Rebello, S., Hsu, K., Nativi-Nicolau, J., Karam, C., Grogan, M., Lousada, I., & Maurer, M. S. (2025). Factors associated with financial toxicity in patients with transthyretin amyloidosis: results from Amyloidosis Research Consortium’s treatment affordability patient and caregiver survey. Amyloid, 1–10. https://doi.org/10.1080/13506129.2025.2462541

Naiki, H., Johnson, M., Walters, K., Carpinteiro, A., Cibeira, M. T., D’Souza, A., Kastritis, E., Maurer, M. S., Mendelson, L., Merlini, G., Muchtar, E., Palladini, G., Riva, E., Sekijima, Y., Westermark, P., Kumar, S., & Schönland, S. O. (2025). Global patterns of amyloid typing: results of a survey by the International Society of Amyloidosis (ISA). Amyloid, 1–6. https://doi.org/10.1080/13506129.2025.2462992

Estrada-Merly, N., Maurer, M. S., & D’Souza, A. (2024). Glaucoma is not seen at a higher prevalence in age-related transthyretin amyloidosis after race stratification. Amyloid, 1–3. https://doi.org/10.1080/13506129.2024.2379394

Petros, F. E., Santos, A. M., Adeniyi, A., Teruya, S., De Los Santos, J., Maurer, M. S., & Agrawal, S. K. (2024). Gait abnormalities in older adults with transthyretin cardiac amyloidosis. Amyloid, 31(2), 116–123. https://doi.org/10.1080/13506129.2024.2319133

Coelho, T., Dispenzieri, A., Grogan, M., Conceição, I., Waddington-Cruz, M., Kristen, A. V., Wixner, J., Diemberger, I., Gonzalez-Moreno, J., Maurer, M. S., Planté-Bordeneuve, V., Garcia-Pavia, P., Tournev, I., Gonzalez-Costello, J., Cariou, E., González-Duarte, A., Glass, O., Chapman, D., … Amass, L. (2023). Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay. Amyloid, 30(4), 445–448. https://doi.org/10.1080/13506129.2023.2229484

Wardhere, A., Bampatsias, D., Fine, N., Garcia-Pavia, P., Grogan, M., Kristen, A. V., Damy, T., Sekijima, Y., & Maurer, M. S. (2023). Heterogeneous worldwide access and pricing of Tafamidis. Amyloid, 31(1), 73–75. https://doi.org/10.1080/13506129.2023.2263620

Kumar, S., Dispenzieri, A., Bhutani, D., Gertz, M., Wechalekar, A., Palladini, G., Comenzo, R., Fonseca, R., Jaccard, A., Kastritis, E., Schönland, S., la Porte, C., Pei, H., Tran, N., & Merlini, G. (2023). Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study. Amyloid, 30(3), 268–278. https://doi.org/10.1080/13506129.2022.2164488

Barroso, F. A., Coelho, T., Dispenzieri, A., Conceição, I., Waddington-Cruz, M., Wixner, J., Maurer, M. S., Rapezzi, C., Planté-Bordeneuve, V., Kristen, A. V., González-Duarte, A., Chapman, D., Stewart, M., & Amass, L. (2022). Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS). Amyloid, 29(3), 175–183. https://doi.org/10.1080/13506129.2022.2043270